Delivery Order SPE2DB20D3101-SPE2DB25FRWS9
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $2,389.66 firm fixed-price delivery order is for the supply of Potassium Iodide 1 GM/ML Solution 30ML, with a completion date of October 17, 2024. The contract is not designated under a specific set-aside program. Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, holds a $999,999,999 Indefinite...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Potassium Iodide 1 GM/ML Solution 30ML, a medical product that supports federal healthcare programs, particularly within military and veterans' healthcare systems. The contract has a ceiling value of $2,334.92 and an ultimate completion date of January 30, 2025. This delivery...
- The Defense Logistics Agency awarded a $1,146.36 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for Potassium Chloride 10 milliequivalents per 100 milliliters solution in 100-milliliter units. The contract is competitively awarded with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of July 21, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of potassium chloride, a critical pharmaceutical commodity. This firm fixed-price delivery order, valued at $2,602.87, is scheduled for completion by October 1, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a $5,932.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp on March 14, 2025, for the supply of Potassium Phosphate 45 mmol/15 ml in 15 ml units, with performance completion targeted for March 17, 2025. This non-set-aside competitive award is performed at the vendor's corporate office location in Conshohocken, Pennsylvania, and represents a child delivery order under AmerisourceBergen's larger contract vehicle with the DLA. AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp valued at $9,927.05 for the supply of Potassium Chloride Extended Release 8 MEQ tablets in quantities of 1,000 units. The award, issued on September 25, 2025, represents a firm fixed price delivery order with an ultimate completion date of September 26, 2025. This non-set-aside contract was competitively awarded and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $7,184.64 to AmerisourceBergen Drug Corp for the supply of Potassium Phosphate 45 mmol/15 ml in 15 ml units. This is a firm fixed price delivery order with an ultimate completion date of September 19, 2025, and no set-aside designation was used in the award. The vendor will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,391.20 to AmerisourceBergen Drug Corp for Potassium Chloride Extended-Release 10 MEQ tablets in quantities of 1,000 units. This contract award, issued on June 24, 2025, with an ultimate completion date of June 25, 2025, represents a firm fixed price delivery order with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a $3,179.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Potassium Chloride Extended Release 10 MEQ on July 30, 2025, with a completion date of July 31, 2025. This non-set-aside contract represents a routine pharmaceutical procurement executed through the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through...
- The Defense Logistics Agency awarded a $1,385.30 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Potassium Phosphate 15 mmol/5 ml in 5 ml vials. This firm fixed-price contract, with an ultimate completion date of August 15, 2025, will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award was not set aside and represents a competitive procurement action under the company's existing contract vehicle with the agency. This delivery order...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRWS9Delivery Order
The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for potassium iodide 1 gm/ml solution in 30ml quantities, valued at $1,542.48. The contract is firm fixed price with no set-aside designation and carries an ultimate completion date of September 29, 2025. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for the defense supply chain. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor headquartered in Pennsylvania. The company has demonstrated substantial capability in fulfilling diverse federal healthcare requirements through its extensive portfolio of competitively awarded contracts with the Defense Logistics Agency and related military healthcare systems. The SPE2DX IDC encompasses a broad range of pharmaceutical products and medical supplies—including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities—enabling the company to support military healthcare programs worldwide and serve customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 9/26/25 |